C4A_2

gene
On this page

Summary

C4A_2 (complement component 4A (Chido/Rodgers blood group), copy 2, HGNC:58753) is a protein-coding gene on chromosome 6p21.33 alternate reference locus.

At a glance

  • MANE Select transcript: NM_001352000

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:58753
Approved symbolC4A_2
Namecomplement component 4A (Chido/Rodgers blood group), copy 2
Location6p21.33 alternate reference locus
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000227746
Entrez110384692

Gene structure

Transcript identifiers

Ensembl transcripts: 0

RefSeq mRNA: 1 — MANE Select: NM_001352000 NM_001352000

Canonical transcript exons

ENST00000421274 — 0 exons

Expression profiles

Top tissues by expression

0 total, by Bgee expression score (0-100, higher = more expressed):

Single-cell (SCXA)

Detected in 4 experiment(s), a significant marker in 2.

ExperimentMarker?Max mean expression
E-GEOD-130473yes294.10
E-MTAB-5061yes18.39
E-GEOD-110499no1226.98
E-GEOD-75688no235.89

Regulation

Is transcription factor: no

Cross-species orthologs

0 orthologs

Protein

Protein identifiers

Canonical reviewed UniProt: None (reviewed: )

All UniProt accessions (1): P0C0L4

RefSeq proteins (1): NP_001338929* (*=MANE)

Domains & families (InterPro)

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

Function

Pathways and Gene Ontology

Reactome pathways

6 pathways

IDPathway
R-HSA-166663Initial triggering of complement
R-HSA-174577Activation of C3 and C5
R-HSA-381426Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
R-HSA-8957275Post-translational protein phosphorylation
R-HSA-977606Regulation of Complement cascade
R-HSA-9920588Dengue virus activates/modulates innate and adaptive immune responses

MSigDB gene sets: 0 (showing top):

GO Biological Process (7): immune system process (GO:0002376), inflammatory response (GO:0006954), complement activation (GO:0006956), complement activation, classical pathway (GO:0006958), innate immune response (GO:0045087), complement activation, GZMK pathway (GO:0160257), positive regulation of apoptotic cell clearance (GO:2000427)

GO Molecular Function (4): complement binding (GO:0001848), complement component C1q complex binding (GO:0001849), endopeptidase inhibitor activity (GO:0004866), protein binding (GO:0005515)

GO Cellular Component (12): extracellular region (GO:0005576), obsolete extracellular space (GO:0005615), endoplasmic reticulum lumen (GO:0005788), plasma membrane (GO:0005886), cell surface (GO:0009986), axon (GO:0030424), dendrite (GO:0030425), cell projection (GO:0042995), neuronal cell body (GO:0043025), synapse (GO:0045202), extracellular exosome (GO:0070062), blood microparticle (GO:0072562)

Reactome top-level categories

Rollup of top-4 pathways:

CategoryPathways
Complement cascade3
Metabolism of proteins1
Post-translational protein modification1
Dengue Virus-Host Interactions1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure4
complement activation2
neuron projection2
biological_process1
defense response1
immune effector process1
activation of immune response1
humoral immune response1
protein activation cascade1
humoral immune response mediated by circulating immunoglobulin1
immune response1
defense response to symbiont1
innate immune response1
apoptotic cell clearance1
positive regulation of phagocytosis1
regulation of apoptotic cell clearance1
protein binding1
opsonin binding1
complement binding1
protein-containing complex binding1
endopeptidase activity1
peptidase inhibitor activity1
endopeptidase regulator activity1
binding1
endoplasmic reticulum1
intracellular organelle lumen1
membrane1
cell periphery1
dendritic tree1
somatodendritic compartment1
cell body1
cell junction1
extracellular vesicle1
extracellular region1

Protein interactions and networks

STRING

0 interactions, top by confidence (×1000):

IntAct

0 interactions, top by confidence:

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

0 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance0
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

0 predictions. Top by Δscore:

AlphaMissense

0 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1003761200 (6:32027148 T>A), RS1012400686 (6:32027039 C>G,T), RS1016876596 (6:32030374 T>C), RS1022362121 (6:32027490 T>G), RS1023879145 (6:32013343 C>G,T), RS1025931829 (6:32030131 A>C,G), RS1027152766 (6:32013179 G>A,T), RS1030969879 (6:32013501 C>T), RS1040725112 (6:32013019 C>T), RS1043957144 (6:32029457 G>A), RS1044841490 (6:32028627 C>T), RS1048112114 (6:32026847 G>A), RS1048557718 (6:32028389 GA>G), RS1053072409 (6:32029307 C>T), RS112636917 (6:32027901 T>G)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 0 entries

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.